The document provides guidance for managing snakebite casualties worldwide based on new clinical practice guidelines. It recommends early administration of region- and syndrome-specific antivenom as the standard of care to neutralize circulating venom before significant damage occurs. The guidelines establish diagnostic criteria and treatment recommendations for three main envenomation syndromes globally. Region-specific sections then provide the recommended first-line antivenoms to stock and use for each syndrome within different geographic commands. The guidelines aim to simplify treatment decisions by enabling syndrome-based diagnosis and management using broad-spectrum antivenoms in most areas.
This document discusses the growing issue of antimicrobial resistance (AMR) and appropriate antibiotic use. It begins by listing several multidrug-resistant organisms of concern. It then discusses common misconceptions around antibiotic use and outlines principles for judicious antibiotic prescribing. The document emphasizes using local antimicrobial susceptibility data to guide empirical therapy and highlights strategies for optimizing antibiotic use, such as de-escalation when culture results are available. It also stresses the importance of antibiotic stewardship programs and following evidence-based guidelines to help curb the rise and spread of drug-resistant infections.
This document discusses the role of prophylactic antibiotics in traumatic cranial CSF leaks. It provides background on CSF leaks, classifications, relevant anatomy, diagnosis and investigations. It then discusses treatment options including conservative measures like bed rest, lumbar drains, and waiting for spontaneous resolution. Surgical management is indicated for extensive injuries or if leaks do not resolve. The document reviews several studies that have found no evidence that prophylactic antibiotics reduce the risk of meningitis in skull fractures or fractures with active CSF leaks. Overall, the choice to use antibiotics depends on individual cases and indications may include perioperative use, active sinusitis, immunocompromised patients, or compound fractures.
This document provides guidelines for antibiotic use, including for severe sepsis, septic shock, and other infections. It discusses evaluation of systemic inflammatory response syndrome and organ dysfunction. Choice of antibiotics depends on the suspected causative organism and its susceptibility. Reserve antibiotics like carbapenems and linezolid require meeting certain criteria. The document recommends measures to control multi-drug resistant organisms and emphasizes rational antibiotic use to reduce antimicrobial resistance.
Septic shock initial 1 hour EM | Jean-Louis Vincent at TBS23scanFOAM
The document discusses sepsis and antibiotic therapy for sepsis. It defines sepsis as a life-threatening organ dysfunction caused by a dysregulated host response to infection. It emphasizes that in severe sepsis cases, such as septic shock, broad-spectrum antibiotics should be administered urgently, within 1-3 hours. For less severe sepsis cases, antibiotics can be started earlier after further evaluation. The goal of early antibiotic therapy is to treat the infection while avoiding overuse of broad-spectrum antibiotics that can promote antimicrobial resistance.
The document provides guidelines for administering the Sinopharm COVID-19 vaccine in Pakistan. It outlines that the vaccine is for those 18 years and older and should be stored between 2-8 degrees Celsius. It describes the target populations in three stages and safety of the vaccine. It provides details on administration, potential adverse effects, their management and reporting. It emphasizes the importance of counseling, monitoring recipients for 30 minutes, and handling any emergencies that may arise from vaccination.
Snake bites and scorpion stings are common causes of envenoming that can be life-threatening. Prompt medical treatment is essential to assess and treat any symptoms of envenoming. The 20-minute whole blood clotting test is a useful bedside assessment to detect coagulopathy from snake bite envenoming. Management involves immobilizing the bite area, establishing IV access, monitoring for symptoms, and administering antivenom as needed. Scorpion stings can cause neurological effects like tachycardia, hypertension, and seizures.
This document discusses the growing issue of antimicrobial resistance (AMR) and appropriate antibiotic use. It begins by listing several multidrug-resistant organisms of concern. It then discusses common misconceptions around antibiotic use and outlines principles for judicious antibiotic prescribing. The document emphasizes using local antimicrobial susceptibility data to guide empirical therapy and highlights strategies for optimizing antibiotic use, such as de-escalation when culture results are available. It also stresses the importance of antibiotic stewardship programs and following evidence-based guidelines to help curb the rise and spread of drug-resistant infections.
This document discusses the role of prophylactic antibiotics in traumatic cranial CSF leaks. It provides background on CSF leaks, classifications, relevant anatomy, diagnosis and investigations. It then discusses treatment options including conservative measures like bed rest, lumbar drains, and waiting for spontaneous resolution. Surgical management is indicated for extensive injuries or if leaks do not resolve. The document reviews several studies that have found no evidence that prophylactic antibiotics reduce the risk of meningitis in skull fractures or fractures with active CSF leaks. Overall, the choice to use antibiotics depends on individual cases and indications may include perioperative use, active sinusitis, immunocompromised patients, or compound fractures.
This document provides guidelines for antibiotic use, including for severe sepsis, septic shock, and other infections. It discusses evaluation of systemic inflammatory response syndrome and organ dysfunction. Choice of antibiotics depends on the suspected causative organism and its susceptibility. Reserve antibiotics like carbapenems and linezolid require meeting certain criteria. The document recommends measures to control multi-drug resistant organisms and emphasizes rational antibiotic use to reduce antimicrobial resistance.
Septic shock initial 1 hour EM | Jean-Louis Vincent at TBS23scanFOAM
The document discusses sepsis and antibiotic therapy for sepsis. It defines sepsis as a life-threatening organ dysfunction caused by a dysregulated host response to infection. It emphasizes that in severe sepsis cases, such as septic shock, broad-spectrum antibiotics should be administered urgently, within 1-3 hours. For less severe sepsis cases, antibiotics can be started earlier after further evaluation. The goal of early antibiotic therapy is to treat the infection while avoiding overuse of broad-spectrum antibiotics that can promote antimicrobial resistance.
The document provides guidelines for administering the Sinopharm COVID-19 vaccine in Pakistan. It outlines that the vaccine is for those 18 years and older and should be stored between 2-8 degrees Celsius. It describes the target populations in three stages and safety of the vaccine. It provides details on administration, potential adverse effects, their management and reporting. It emphasizes the importance of counseling, monitoring recipients for 30 minutes, and handling any emergencies that may arise from vaccination.
Snake bites and scorpion stings are common causes of envenoming that can be life-threatening. Prompt medical treatment is essential to assess and treat any symptoms of envenoming. The 20-minute whole blood clotting test is a useful bedside assessment to detect coagulopathy from snake bite envenoming. Management involves immobilizing the bite area, establishing IV access, monitoring for symptoms, and administering antivenom as needed. Scorpion stings can cause neurological effects like tachycardia, hypertension, and seizures.
Chair and Presenter Taofeek K. Owonikoko, MD, PhD, Hossein Borghaei, DO, MS, and Anne Chiang, MD, PhD, FASCO, prepared useful Practice Aids pertaining to small cell lung cancer for this CME/MOC/AAPA activity titled “Harnessing the Power of the Latest Clinical and Research Advances in SCLC: How to Accelerate Progress and Improve Patient Outcomes With Current and Emerging Therapies.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at https://bit.ly/46zyU93. CME/MOC/AAPA credit will be available until January 2, 2025.
The document provides information on Covid-19 cases worldwide and in the United States. It discusses planning for surges in critical care needs at UCSD Medical Center, including models for staffing ICU units with both ICU and non-ICU nurses. It also covers guidelines and strategies for diagnosis, treatment, and management of critically ill Covid-19 patients, including ventilation, use of sedatives, ECMO, and investigational therapies.
This document provides guidelines for the management of severe sepsis and septic shock from an international collaboration of medical societies. It includes recommendations for initial resuscitation, infection diagnosis and treatment, source control, and hemodynamic support. The key recommendations are:
1) Protocolized resuscitation within the first 6 hours with goals of central venous pressure 8-12 mmHg, mean arterial pressure ≥65 mmHg, urine output ≥0.5 mL/kg/hr, and central venous oxygen saturation ≥70%.
2) Administration of broad-spectrum intravenous antibiotics within 1 hour of recognition of septic shock or severe sepsis.
3) Consideration of source control, such as drainage of infection sites, within 12 hours
Kumar m, tiwari l. snake bite a review jpcc 2018Lokesh Tiwari
Snake bite is a common but under-reported medical emergency accounting for 0.5% of all deaths with greater risk of fatal envenomation in children. In India, four species of venomous snake are most common but better classification of medically significant species is warranted. Snake venom is a mixture of peptides with enzymatic & toxic properties which mediate activation of cytokine cascades along with organ specific toxicities, manifesting into local and systemic symptoms. The syndromic approach of attributing a constellation of signs & symptoms to a particular family of venomous snake has clinical acceptance but overlaps exist. Management of snake bite victim starts with a first aid measures of reassurance, immobilization and quick transfer to hospital. Measures such as application of tourniquet, incision and suction are harmful & should not be done. On arrival at hospital, triage and stabilization of Airway, Breathing & Circulation (ABC) is done followed by a focused assessment to ascertain the severity of envenomation. Antivenom treatment is the mainstay of snake bite management. ASV should be started only when specific indications such as signs of neurotoxicity, coagulopathy, hypotension, hematuria are present. Indiscriminate use of ASV is strongly condemned.Currently 8-10 vials of ASV as initial dose with a maximum of 25 vials is recommended. There is no role of test dose of ASV. Measures to treat any ASV induced anaphylaxis should be ready prior to start of ASV treatment. Supportive treatment is as important in determining the final outcome of envenomation as ASV
Anesthetic risk, quality improvement and liability●๋•αηкιтα madan
This document discusses anesthesia risk and mortality. It provides estimates from various studies that anesthesia-related mortality rates range from less than 1 per 10,000 anesthetics to 1 per 1,560 anesthetics historically. Common complications discussed include nerve injuries, awareness during general anesthesia, eye/dental injuries, and postoperative cognitive dysfunction in elderly patients. Risk management strategies to minimize liability like adherence to standards of care, vigilance, documentation, and informed consent are also outlined.
Dengue fever is caused by dengue virus, which has four serotypes. It is transmitted by the bites of infected Aedes mosquitoes. The document discusses the epidemiology, clinical features, diagnosis, treatment and control of dengue fever. It outlines how to conduct emergency mosquito control operations and treat patients during outbreaks through vector control methods like spraying and reducing breeding sites, and maintaining fluid volume for severe cases in hospitals. The goal is to eliminate infected mosquitoes and break transmission, while providing care to patients.
Dengue fever is caused by dengue virus, which has four serotypes. It is transmitted by the bites of infected Aedes mosquitoes. The document discusses the epidemiology, clinical features, diagnosis, treatment and control of dengue fever. It describes how dengue is controlled through emergency mosquito control measures like insecticide spraying and source reduction, as well as through treatment of patients in hospitals. Personal protective measures, larval source reduction, and integrated vector management strategies are important for long-term prevention and control of dengue transmission.
The document discusses the evolution of implantable cardioverter defibrillators (ICDs) from their early development to modern devices. It notes that early ICDs from the 1980s were large, requiring abdominal implantation through invasive surgery, while later small devices from the 1980s could be implanted pectorally through less invasive procedures. The document outlines key improvements over time, including smaller size, longer battery life, programmability, and reduced complications and mortality. Remote monitoring is also discussed as providing benefits like earlier detection of arrhythmias and improved outcomes.
The document summarizes information and recommendations regarding the Covid-19 pandemic from the perspective of intensive care and critical care specialists. It provides worldwide case statistics and outlines anticipated critical care bed needs for a hospital. It also discusses ventilation strategies, the use of ECMO, guidelines from medical societies, PPE recommendations, management of shock, antibiotics, experimental drug treatments and ongoing clinical trials. The overall focus is on evaluating and treating critically ill Covid-19 patients from an intensive care perspective.
The document summarizes information and recommendations regarding the Covid-19 pandemic from the perspective of intensive care and critical care specialists. It provides worldwide case statistics and projections for hospital bed and ventilator needs in California. Guidelines are presented on testing, diagnosis, treatment strategies including ventilation, use of sedatives, ECMO, and experimental drugs. Risk stratification, PPE guidance, and management of complications like shock are also addressed. Clinical trials and the potential use of convalescent plasma are discussed.
The document summarizes information and recommendations regarding the Covid-19 pandemic from the perspective of intensive care and critical care specialists. It provides worldwide case statistics and projections for hospital bed and ventilator needs in California. Guidelines are presented on testing, diagnosis, treatment strategies including ventilation, use of sedatives, ECMO, and experimental drugs. Risk stratification, PPE guidance, and management of complications like shock are also addressed. Clinical trials and the potential use of convalescent plasma are discussed.
1. Guidelines for the rational use of antibiotics and.pptxAnusha Are
Guidelines for the rational use of antibiotics and surgical prophylaxis provide definitions and guidelines around antibiotic use for surgery. They discuss defining surgery and why antibiotics are needed, risk factors that promote infection, classifying surgical wounds, and goals of antibiotic prophylaxis including reducing surgical site infections. The guidelines provide recommendations on antibiotic selection, timing of administration before and after surgery, and dosing to effectively prevent infections while minimizing antibiotic resistance and costs.
This document summarizes a seminar presentation on ICU care bundles. The presentation outlines several care bundles including the ABCDEF bundle. The ABCDEF bundle focuses on assessing, preventing, and managing pain; both spontaneous awakening trials and spontaneous breathing trials; choice of sedation and analgesia; assessing, preventing, and managing delirium; and early mobility and exercise. Implementing bundles like the ABCDEF bundle can help optimize patient outcomes by reducing ICU delirium and the duration of mechanical ventilation and ICU stays.
Vascular graft infection do we need antimicrobial graftsuvcd
Vascular graft infections pose serious risks and costs. Preventing surgical site infections is a high priority. While various preventive measures have been attempted, graft infections still occur. New antimicrobial grafts containing combinations of agents like silver acetate and triclosan show promise in inhibiting early microbial colonization based on in vitro studies, but more research is needed to determine their efficacy in preventing infections in vivo. Antimicrobial grafts may help reduce the morbidity, mortality, and economic burden of vascular graft infections if shown to be effective through further investigation.
This document discusses three cases of infective endocarditis. The first case involves a patient with SLE and antiphospholipid syndrome who presented with an embolism and was found to have vegetations on their aortic valve, diagnosing Libman-Sacks endocarditis. The second case involves a patient who developed multiple embolic infarctions and a vegetation on their mitral valve after developing leg edema and deep vein thrombosis following pancreatic cancer treatment, diagnosing marantic endocarditis/nonbacterial thrombotic endocarditis. The third case involves a patient who presented with fever and murmur following prostate surgery who was diagnosed with infective endocarditis by echocardiogram showing vegetations and
This document summarizes guidelines for the management of febrile neutropenia. It describes definitions of fever and neutropenia and risk factors. Initial evaluation involves blood cultures, site-specific cultures as indicated, and monitoring. Risk is stratified using tools like the MASCC index. Prophylaxis includes hand hygiene, oral care, and sometimes antibiotics or antifungals. Empiric antibiotic therapy is recommended, with modifications based on risk and response. Therapy typically continues until resolution of fever and recovery of neutrophils. Empiric antifungals may be considered for persistent fever.
Antimicrobial drug sensitivity testing and therapeutic use in veterinary prac...Bhoj Raj Singh
This document discusses antimicrobial drug sensitivity testing and therapeutic use in veterinary practice. It provides information on different antimicrobial susceptibility testing methods including disc diffusion tests, minimum inhibitory concentration tests, and automated methods. It describes how to interpret the results of these tests and highlights the importance of testing in selecting effective antimicrobial treatment and monitoring resistance patterns. The document also discusses guidelines for judicious antimicrobial use in veterinary practice.
This document provides information about adverse events following immunization (AEFI), specifically addressing toxic shock syndrome (TSS) and anaphylaxis. It discusses program errors as a common cause of AEFI and outlines proper vaccine handling, storage, and administration to minimize errors. The document also describes signs and symptoms of TSS and anaphylaxis, as well as their treatment, including use of epinephrine, IV fluids, antibiotics, and management of affected organ systems. It emphasizes the importance of rapid transport and treatment of serious AEFI cases.
View the clinical evidence from the Angel Catheter Pivotal Study. This investigation was concluded in December 2015. The primary objective of this clinical trial was to evaluate the safety and effectiveness of the Angel® Catheter in subjects at high risk of PE and with recognized contraindications to standard pharmacological therapy.
The Angel Catheter received 510(k) Clearance in July 2016.
Email sbrewer@bio2medical.com to request a meeting to review the study results and device.
The facial nerve, also known as cranial nerve VII, is one of the 12 cranial nerves originating from the brain. It's a mixed nerve, meaning it contains both sensory and motor fibres, and it plays a crucial role in controlling various facial muscles, as well as conveying sensory information from the taste buds on the anterior two-thirds of the tongue.
Sectional dentures for microstomia patients.pptxSatvikaPrasad
Microstomia, characterized by an abnormally small oral aperture, presents significant challenges in prosthodontic treatment, including limited access for examination, difficulties in impression making, and challenges with prosthesis insertion and removal. To manage these issues, customized impression techniques using sectional trays and elastomeric materials are employed. Prostheses may be designed in segments or with flexible materials to facilitate handling. Minimally invasive procedures and the use of digital technologies can enhance patient comfort. Education and training for patients on prosthesis care and maintenance are crucial for compliance. Regular follow-up and a multidisciplinary approach, involving collaboration with other specialists, ensure comprehensive care and improved quality of life for microstomia patients.
Chair and Presenter Taofeek K. Owonikoko, MD, PhD, Hossein Borghaei, DO, MS, and Anne Chiang, MD, PhD, FASCO, prepared useful Practice Aids pertaining to small cell lung cancer for this CME/MOC/AAPA activity titled “Harnessing the Power of the Latest Clinical and Research Advances in SCLC: How to Accelerate Progress and Improve Patient Outcomes With Current and Emerging Therapies.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at https://bit.ly/46zyU93. CME/MOC/AAPA credit will be available until January 2, 2025.
The document provides information on Covid-19 cases worldwide and in the United States. It discusses planning for surges in critical care needs at UCSD Medical Center, including models for staffing ICU units with both ICU and non-ICU nurses. It also covers guidelines and strategies for diagnosis, treatment, and management of critically ill Covid-19 patients, including ventilation, use of sedatives, ECMO, and investigational therapies.
This document provides guidelines for the management of severe sepsis and septic shock from an international collaboration of medical societies. It includes recommendations for initial resuscitation, infection diagnosis and treatment, source control, and hemodynamic support. The key recommendations are:
1) Protocolized resuscitation within the first 6 hours with goals of central venous pressure 8-12 mmHg, mean arterial pressure ≥65 mmHg, urine output ≥0.5 mL/kg/hr, and central venous oxygen saturation ≥70%.
2) Administration of broad-spectrum intravenous antibiotics within 1 hour of recognition of septic shock or severe sepsis.
3) Consideration of source control, such as drainage of infection sites, within 12 hours
Kumar m, tiwari l. snake bite a review jpcc 2018Lokesh Tiwari
Snake bite is a common but under-reported medical emergency accounting for 0.5% of all deaths with greater risk of fatal envenomation in children. In India, four species of venomous snake are most common but better classification of medically significant species is warranted. Snake venom is a mixture of peptides with enzymatic & toxic properties which mediate activation of cytokine cascades along with organ specific toxicities, manifesting into local and systemic symptoms. The syndromic approach of attributing a constellation of signs & symptoms to a particular family of venomous snake has clinical acceptance but overlaps exist. Management of snake bite victim starts with a first aid measures of reassurance, immobilization and quick transfer to hospital. Measures such as application of tourniquet, incision and suction are harmful & should not be done. On arrival at hospital, triage and stabilization of Airway, Breathing & Circulation (ABC) is done followed by a focused assessment to ascertain the severity of envenomation. Antivenom treatment is the mainstay of snake bite management. ASV should be started only when specific indications such as signs of neurotoxicity, coagulopathy, hypotension, hematuria are present. Indiscriminate use of ASV is strongly condemned.Currently 8-10 vials of ASV as initial dose with a maximum of 25 vials is recommended. There is no role of test dose of ASV. Measures to treat any ASV induced anaphylaxis should be ready prior to start of ASV treatment. Supportive treatment is as important in determining the final outcome of envenomation as ASV
Anesthetic risk, quality improvement and liability●๋•αηкιтα madan
This document discusses anesthesia risk and mortality. It provides estimates from various studies that anesthesia-related mortality rates range from less than 1 per 10,000 anesthetics to 1 per 1,560 anesthetics historically. Common complications discussed include nerve injuries, awareness during general anesthesia, eye/dental injuries, and postoperative cognitive dysfunction in elderly patients. Risk management strategies to minimize liability like adherence to standards of care, vigilance, documentation, and informed consent are also outlined.
Dengue fever is caused by dengue virus, which has four serotypes. It is transmitted by the bites of infected Aedes mosquitoes. The document discusses the epidemiology, clinical features, diagnosis, treatment and control of dengue fever. It outlines how to conduct emergency mosquito control operations and treat patients during outbreaks through vector control methods like spraying and reducing breeding sites, and maintaining fluid volume for severe cases in hospitals. The goal is to eliminate infected mosquitoes and break transmission, while providing care to patients.
Dengue fever is caused by dengue virus, which has four serotypes. It is transmitted by the bites of infected Aedes mosquitoes. The document discusses the epidemiology, clinical features, diagnosis, treatment and control of dengue fever. It describes how dengue is controlled through emergency mosquito control measures like insecticide spraying and source reduction, as well as through treatment of patients in hospitals. Personal protective measures, larval source reduction, and integrated vector management strategies are important for long-term prevention and control of dengue transmission.
The document discusses the evolution of implantable cardioverter defibrillators (ICDs) from their early development to modern devices. It notes that early ICDs from the 1980s were large, requiring abdominal implantation through invasive surgery, while later small devices from the 1980s could be implanted pectorally through less invasive procedures. The document outlines key improvements over time, including smaller size, longer battery life, programmability, and reduced complications and mortality. Remote monitoring is also discussed as providing benefits like earlier detection of arrhythmias and improved outcomes.
The document summarizes information and recommendations regarding the Covid-19 pandemic from the perspective of intensive care and critical care specialists. It provides worldwide case statistics and outlines anticipated critical care bed needs for a hospital. It also discusses ventilation strategies, the use of ECMO, guidelines from medical societies, PPE recommendations, management of shock, antibiotics, experimental drug treatments and ongoing clinical trials. The overall focus is on evaluating and treating critically ill Covid-19 patients from an intensive care perspective.
The document summarizes information and recommendations regarding the Covid-19 pandemic from the perspective of intensive care and critical care specialists. It provides worldwide case statistics and projections for hospital bed and ventilator needs in California. Guidelines are presented on testing, diagnosis, treatment strategies including ventilation, use of sedatives, ECMO, and experimental drugs. Risk stratification, PPE guidance, and management of complications like shock are also addressed. Clinical trials and the potential use of convalescent plasma are discussed.
The document summarizes information and recommendations regarding the Covid-19 pandemic from the perspective of intensive care and critical care specialists. It provides worldwide case statistics and projections for hospital bed and ventilator needs in California. Guidelines are presented on testing, diagnosis, treatment strategies including ventilation, use of sedatives, ECMO, and experimental drugs. Risk stratification, PPE guidance, and management of complications like shock are also addressed. Clinical trials and the potential use of convalescent plasma are discussed.
1. Guidelines for the rational use of antibiotics and.pptxAnusha Are
Guidelines for the rational use of antibiotics and surgical prophylaxis provide definitions and guidelines around antibiotic use for surgery. They discuss defining surgery and why antibiotics are needed, risk factors that promote infection, classifying surgical wounds, and goals of antibiotic prophylaxis including reducing surgical site infections. The guidelines provide recommendations on antibiotic selection, timing of administration before and after surgery, and dosing to effectively prevent infections while minimizing antibiotic resistance and costs.
This document summarizes a seminar presentation on ICU care bundles. The presentation outlines several care bundles including the ABCDEF bundle. The ABCDEF bundle focuses on assessing, preventing, and managing pain; both spontaneous awakening trials and spontaneous breathing trials; choice of sedation and analgesia; assessing, preventing, and managing delirium; and early mobility and exercise. Implementing bundles like the ABCDEF bundle can help optimize patient outcomes by reducing ICU delirium and the duration of mechanical ventilation and ICU stays.
Vascular graft infection do we need antimicrobial graftsuvcd
Vascular graft infections pose serious risks and costs. Preventing surgical site infections is a high priority. While various preventive measures have been attempted, graft infections still occur. New antimicrobial grafts containing combinations of agents like silver acetate and triclosan show promise in inhibiting early microbial colonization based on in vitro studies, but more research is needed to determine their efficacy in preventing infections in vivo. Antimicrobial grafts may help reduce the morbidity, mortality, and economic burden of vascular graft infections if shown to be effective through further investigation.
This document discusses three cases of infective endocarditis. The first case involves a patient with SLE and antiphospholipid syndrome who presented with an embolism and was found to have vegetations on their aortic valve, diagnosing Libman-Sacks endocarditis. The second case involves a patient who developed multiple embolic infarctions and a vegetation on their mitral valve after developing leg edema and deep vein thrombosis following pancreatic cancer treatment, diagnosing marantic endocarditis/nonbacterial thrombotic endocarditis. The third case involves a patient who presented with fever and murmur following prostate surgery who was diagnosed with infective endocarditis by echocardiogram showing vegetations and
This document summarizes guidelines for the management of febrile neutropenia. It describes definitions of fever and neutropenia and risk factors. Initial evaluation involves blood cultures, site-specific cultures as indicated, and monitoring. Risk is stratified using tools like the MASCC index. Prophylaxis includes hand hygiene, oral care, and sometimes antibiotics or antifungals. Empiric antibiotic therapy is recommended, with modifications based on risk and response. Therapy typically continues until resolution of fever and recovery of neutrophils. Empiric antifungals may be considered for persistent fever.
Antimicrobial drug sensitivity testing and therapeutic use in veterinary prac...Bhoj Raj Singh
This document discusses antimicrobial drug sensitivity testing and therapeutic use in veterinary practice. It provides information on different antimicrobial susceptibility testing methods including disc diffusion tests, minimum inhibitory concentration tests, and automated methods. It describes how to interpret the results of these tests and highlights the importance of testing in selecting effective antimicrobial treatment and monitoring resistance patterns. The document also discusses guidelines for judicious antimicrobial use in veterinary practice.
This document provides information about adverse events following immunization (AEFI), specifically addressing toxic shock syndrome (TSS) and anaphylaxis. It discusses program errors as a common cause of AEFI and outlines proper vaccine handling, storage, and administration to minimize errors. The document also describes signs and symptoms of TSS and anaphylaxis, as well as their treatment, including use of epinephrine, IV fluids, antibiotics, and management of affected organ systems. It emphasizes the importance of rapid transport and treatment of serious AEFI cases.
View the clinical evidence from the Angel Catheter Pivotal Study. This investigation was concluded in December 2015. The primary objective of this clinical trial was to evaluate the safety and effectiveness of the Angel® Catheter in subjects at high risk of PE and with recognized contraindications to standard pharmacological therapy.
The Angel Catheter received 510(k) Clearance in July 2016.
Email sbrewer@bio2medical.com to request a meeting to review the study results and device.
The facial nerve, also known as cranial nerve VII, is one of the 12 cranial nerves originating from the brain. It's a mixed nerve, meaning it contains both sensory and motor fibres, and it plays a crucial role in controlling various facial muscles, as well as conveying sensory information from the taste buds on the anterior two-thirds of the tongue.
Sectional dentures for microstomia patients.pptxSatvikaPrasad
Microstomia, characterized by an abnormally small oral aperture, presents significant challenges in prosthodontic treatment, including limited access for examination, difficulties in impression making, and challenges with prosthesis insertion and removal. To manage these issues, customized impression techniques using sectional trays and elastomeric materials are employed. Prostheses may be designed in segments or with flexible materials to facilitate handling. Minimally invasive procedures and the use of digital technologies can enhance patient comfort. Education and training for patients on prosthesis care and maintenance are crucial for compliance. Regular follow-up and a multidisciplinary approach, involving collaboration with other specialists, ensure comprehensive care and improved quality of life for microstomia patients.
Joker Wigs has been a one-stop-shop for hair products for over 26 years. We provide high-quality hair wigs, hair extensions, hair toppers, hair patch, and more for both men and women.
This particular slides consist of- what is hypotension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is the summary of hypotension:
Hypotension, or low blood pressure, is when the pressure of blood circulating in the body is lower than normal or expected. It's only a problem if it negatively impacts the body and causes symptoms. Normal blood pressure is usually between 90/60 mmHg and 120/80 mmHg, but pressures below 90/60 are generally considered hypotensive.
Emotional and Behavioural Problems in Children - Counselling and Family Thera...PsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
The Importance of Black Women Understanding the Chemicals in Their Personal C...bkling
Certain chemicals, such as phthalates and parabens, can disrupt the body's hormones and have significant effects on health. According to data, hormone-related health issues such as uterine fibroids, infertility, early puberty and more aggressive forms of breast and endometrial cancers disproportionately affect Black women. Our guest speaker, Jasmine A. McDonald, PhD, an Assistant Professor in the Department of Epidemiology at Columbia University in New York City, discusses the scientific reasons why Black women should pay attention to specific chemicals in their personal care products, like hair care, and ways to minimize their exposure.
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
At Malayali Kerala Spa Ajman, Full Service includes individualized care for every client. We specifically design each massage session for the individual needs of the client. Our therapists are always willing to adjust the treatments based on the client's instruction and feedback. This guarantees that every client receives the treatment they expect.
By offering a variety of massage services, our Ajman Spa Massage Center can tackle physical, mental, and emotional illnesses. In addition, efficient identification of specific health conditions and designing treatment plans accordingly can significantly enhance the quality of massaging.
At Malayali Kerala Spa Ajman, we firmly believe that everyone should have the option to experience top-quality massage services regularly. To achieve that goal we offer cheap massage services in Ajman.
If you are interested in experiencing transformative massage treatment at Malayali Kerala Spa Ajman, you can use our Ajman Massage Center WhatsApp Number to schedule your next massage session.
Contact @ +971 529818279
Visit @ https://malayalikeralaspaajman.com/
CHAPTER 1 SEMESTER V COMMUNICATION TECHNIQUES FOR CHILDREN.pdfSachin Sharma
Here are some key objectives of communication with children:
Build Trust and Security:
Establish a safe and supportive environment where children feel comfortable expressing themselves.
Encourage Expression:
Enable children to articulate their thoughts, feelings, and experiences.
Promote Emotional Understanding:
Help children identify and understand their own emotions and the emotions of others.
Enhance Listening Skills:
Develop children’s ability to listen attentively and respond appropriately.
Foster Positive Relationships:
Strengthen the bond between children and caregivers, peers, and other adults.
Support Learning and Development:
Aid cognitive and language development through engaging and meaningful conversations.
Teach Social Skills:
Encourage polite, respectful, and empathetic interactions with others.
Resolve Conflicts:
Provide tools and guidance for children to handle disagreements constructively.
Encourage Independence:
Support children in making decisions and solving problems on their own.
Provide Reassurance and Comfort:
Offer comfort and understanding during times of distress or uncertainty.
Reinforce Positive Behavior:
Acknowledge and encourage positive actions and behaviors.
Guide and Educate:
Offer clear instructions and explanations to help children understand expectations and learn new concepts.
By focusing on these objectives, communication with children can be both effective and nurturing, supporting their overall growth and well-being.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
Mental Health and well-being Presentation. Exploring innovative approaches and strategies for enhancing mental well-being. Discover cutting-edge research, effective strategies, and practical methods for fostering mental well-being.
1. JTS Global Snake Envenomation Management (CPG ID: 81)
GLOBAL SNAKE ENVENOMATION MANAGEMENT (CPG ID:81)
New JTS Clinical Practice Guidelines for Management of Snakebite Casualties Worldwide
1
2. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Snakebites casualties have already happened
Snakebites pose a serious risk in the austere and operational medicine environment!
Examples of snakebites reported by US Military
• Snakebite fatality in AFRICOM in 2015: US soldier killed by snakebite
(suspected mamba bite) while on base at Manda Bay, Kenya1
• Estimate at least 400 US service members treated for snakebites during Vietnam
war2
• Pit viper envenomation in MWD3
• Numerous documented cases of local partner forces and local nationals treated
at US hospitals in Afghanistan/Iraq4,5
• One US military study estimated monthly snakebite incidence of 4.9 bites per
10,000 US soldiers from 2005 – 2006 in Iraq/Afghanistan6
2
3. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Snakebites casualties have already happened
A few additional examples from French, British, Israeli militaries…
Recent data from French Military:
• French soldier died of presumed cardiovascular collapse in < 1 hour after confirmed
burrowing asp bite in Senegal (early 2000’s)7
• French soldier bitten by spitting cobra in Mali (2013)7,8
• 9 snakebites treated with antivenom during operations in Africa 2015 – 20178
• 3 viper bites in northern Mali
• 1 green mamba bite in Ivory Coast
• 5 viper bites in Djibouti
British Military: UK soldier w/viper bite on Iran/Iraq border in 20049, another with horned
viper envenomation Croatia 20179, spitting cobras/others in Africa, etc
Israel (IDF): annual incidence of 32 – 52 snakebite cases/100,000 soldiers (1993 – 97)10
3
4. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Austere environments + long or unpredictable
evacuation times = recipe for disaster
Key to preventing death and disability is early treatment!
• There is no benefit to delaying antivenom treatment until
the patient arrives at Role 2 or Role 3.
• Treatment delays only enable preventable injuries to
progress until antivenom is given.
Why do we need to change the way these bites are managed?
Every hour wasted between bite and antivenom
treatment = ↑ risk death / permanent disability
Early antivenom can prevent the following:
NEUROTOXINS bind receptors and cause respiratory paralysis
HEMOTOXINS interfere with clotting and cause systemic internal
and external bleeding (GI, brain, abdomen, hemorrhagic shock)
CYTOTOXINS cause irreversible tissue injury/necrosis
4
5. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Modern antivenoms enable safe & effective field treatment
Modern antivenoms recommended in this CPG have
evolved significantly from their predecessors:
• SAFETY: Risk of anaphylaxis has decreased from >50% in many older
products to <1% with most recommended 1st line antivenoms in CPG
• SIMPLICITY: Broad-spectrum polyvalent antivenoms enable treatment
based on clinical syndrome rather than snake species and enable non-
experts to diagnose and treat appropriately
• FIELD STABILITY: JTS working group has identified field-stable, freeze-
dried antivenom options for every COCOM except EUCOM at this time
(EUCOM expected to be resolved shortly).
Photo by Thomas Nicolon for
National Geographic
5
6. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
What has changed with the new snakebite CPGs?
1) Early administration of the appropriate regionally- and syndrome-specific antivenom is
the standard of care for snake envenomation treatment worldwide.
2) In AFRICOM/CENTCOM/INDOPACOM/SOUTHCOM, recommended first line antivenoms
listed for each region in this CPG should be:
i. Stocked in the aid station and carried into the field by all units with qualified
paramedic-level and higher providers (including 18D, SOCM, PJ, IDC, IDMT, etc.)
ii. Administered ASAP in the field, at or near the point of injury, prior to medevac for
all patients meeting treatment criteria in order to neutralize circulating venom
before significant and potentially irreversible damage has occurred
3) Additional stock of the appropriate antivenoms listed in this CPG should be maintained
in all role 2/3 settings worldwide
New standard of care for snakebite patients worldwide recommended
by the JTS envenomation working group in CPG 81:
6
7. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
What is in the new CPGs and how should you use them?
7
8. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
HEMO
COAGULOPATHY
(VICC)
LOCAL
BLEEDING
SYSTEMIC
BLEEDING
CYTO
SEVERE
PAIN
PROGRESSIVE
EDEMA
TISSUE
DESTRUCTION
NEURO
BILATERAL
PTOSIS
DESCENDING
PARALYSIS
DYSPNEA
/ AMS
3 major syndromes 3 major signs of each
1. Every snake that can kill or injure you worldwide will ultimately present with one or more of the three major
syndromes of snake envenomations.
2. Snakebite management in the CPGs is guided by the envenomation syndrome rather than the snake species
8
9. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Universal approach to snakebite: Part I
The first half of the new CPGs = UNIVERSAL
APPROACH to all snakebite patients worldwide
1. Clinical triads for the 3 major syndromes
2. Initial priorities and resuscitation
3. Snakebite-specific focused assessment and
tests for austere and advanced care settings
4. Transport decisions
9
10. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Universal approach to snakebite: Part I
Table 1: Simplified universal diagnosis and
treatment criteria for snakebite worldwide
• Provides S/Sx, severity scale, and treatment
criteria for all 3 major snakebite syndromes
First line antivenoms recommended for each
region are summarized in table 2
• Flowcharts for which antivenom to use are
provided later in the regional sections
10
1
11. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Universal approach to snakebite: Part I
Adjunct treatments and supportive care section
covers all non-antivenom treatments such as
airway management, blood products, analgesia,
wound care, etc… …and also covers ongoing monitoring and
treatment information and discharge
guidelines
11
12. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Universal approach to snakebite: Part II
Criteria for initial antivenom treatment & repeat doses:
= longer and more detailed version of the information
summarized in table 1 earlier
Table 1 is the quick reference version
12
13. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Universal approach to snakebite: Part III
The next sections cover the prevention and management of all
early and late adverse reactions to antivenom treatment
NOTE: anaphylaxis treatment protocol is listed in this section.
Anaphylaxis should be very rare (a fraction of 1% of patients)
with first line antivenoms recommended in this CPG
13
14. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Universal approach to snakebite: Part IV
Universal approach section ends with the following information:
• What to do if antivenom is unavailable
• Treatment of snakebites in military
working dogs
• Give same doses of same
antivenoms as recommended for
humans in the CPG
• Late presentations
• No time limit for when antivenom
can be given
• Outdated interventions you should not
perform (i.e. cut and suck, tourniquet,
etc)
• Spitting cobras are found in Africa and
Asia and are can cause blindness by
spitting venom into the eyes from
several meters away
• Spitting cobra venom in the eyes should
be treated with irrigation like a chemical
exposure and should not be treated
with antivenom
• Bites from spitting cobras should
receive antivenom
14
15. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
How to use regionally-specific treatment guideline sections
15
16. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
How to use the regionally-specific treatment guidelines
To simplify management decisions, each COCOM has a separate treatment section that
covers which antivenoms to stock, what to use for each syndrome, and how to use them
Whenever possible, broad-spectrum,
field-stable antivenoms have been
recommended to enable syndromic
diagnosis and treatment at the point
of injury without the need to identify
the species responsible for the bite!
16
17. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
How to use the regional treatment guidelines
The first paragraph contains brief summary detailing:
1. If a broad-spectrum, field-stable antivenom option exist for this COCOM
2. If treatment in this COCOM can be based solely on syndrome without requiring snake ID
3. If field treatment at the point of injury is recommended for this COCOM
17
18. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
How to use the regional treatment guidelines
Simplified Dx & Tx summary table with
first line antivenoms for each COCOM:
1. These tables list the recommended
1st line antivenoms for each
syndrome
Note that 1st line antivenoms for
SOUTHCOM are divided into neurotoxic
syndrome and hemotoxic/cytotoxic
syndromes because no single-source
treatment option exists…
18
19. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
How to use the regional treatment guidelines
Simplified Dx & Tx summary table with
first line antivenoms for each COCOM:
1. These tables list the recommended
1st line antivenoms for each
syndrome
In AFRICOM, the 1st line antivenom
section is not divided because there is a
single-source antivenom that covers all
three syndromes
19
20. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Algorithms for each COCOM simplify antivenom selection
To select the appropriate antivenom for your
deployment location, follow the COCOM-
specific antivenom algorithms!
These algorithms cover all antivenom options
for each COCOM, not just 1st line options
20
21. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Select the appropriate antivenom from the regional algorithm
Important:
Algorithms start with REGION and then move to
SYNDROME. Both of these must be accounted for
to ensure correct antivenom is selected
21
22. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Select the appropriate antivenom from the regional algorithm
The most complex antivenom algorithm is in
INDOPACOM due to regional coverage gaps
between antivenoms designed for Southeast
Asia vs East Asia.
22
23. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Select the appropriate antivenom from the regional algorithm
Yellow backgrounds indicate that an antivenom is
both broad-spectrum and field-stable.
SOUTHCOM example:
• There is a broad-spectrum, freeze-dried/field-
stable antivenom that covers all hemotoxic and
cytotoxic syndromes in SOUTHCOM
• For neurotoxic syndromes, there is one neuro
polyvalent for Central American and another
for South America (and neither product is
freeze-dried)
23
24. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Next step: refer to specific instructions for the antivenom you selected
Each antivenom in the CPG has it’s own
page covering indications, geographic
coverage, safety, efficacy, dosing,
preparation, and administration
Always refer to the individual product
sheets for useful information and specific
instructions prior to administration!
24
25. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Breakdown of the information on each specific antivenom product page
Formulation and storage requirements; peer-
reviewed references for this antivenom
Header format =
1st/2nd/3rd line (COCOM – Specific areas
covered): Product Abbreviation
Quick summary: field-
stability, indications, dosing
Recommendation on whether to carry this product
in the field; details on storage requirements
Additional info on safety, species coverage, and
recommendations on whether to pretreat for reactions
Initial and additional dosing for each syndrome
Instructions for how to mix and
administer this specific antivenom
Manufacturer – Official
Product Name
25
26. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
1st line antivenoms may be indicated as 2nd or 3rd line for a different region
Some products are indicated as 1st line for one region and 2nd or 3rd line for a different region
26
27. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Conclusions
• New CPGs enable every qualified provider to safely and effectively diagnose and treat
snakebites in the field using broad-spectrum, regionally-specific antivenoms and targeted
supportive measures
• They also eliminate the need to identify the species of snake responsible for the bite and facilitate
treatment based entirely off of the clinical presentation and evolution of the patient
• Refer to the Universal Approach to Snakebite for detailed instructions and a stepwise
approach to snakebite management throughout the course of care.
• Determine the appropriate first line antivenom for your area of operations prior to deployment
using the individual antivenom algorithms for your combatant command
• Refer to specific product sheets for all relevant information on how and when to use the
antivenoms you have on hand
• Goal of the new CPGs is to eliminate all preventable snakebite death and disability by bringing
antivenom treatment to the point of injury
27
28. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Time to shift the thinking on antivenoms
is to is to
as
Antivenom for snakebites = whole blood and a surgeon for trauma
New field stable antivenoms and a symptom-driven syndromic approach to
snakebite management make field treatment the new standard of care
(…and you don’t need to identify the snake)
28
29. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Final wisdom from the late herpetologist Sanda Ashe
“Antivenom is like the Texan’s gun – he doesn’t need
it often, but when he does he needs it real bad”
Don’t be afraid to give it in the field when it is needed!
29
30. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
Contact the working group for additional information
CONTACT INFORMATION
• For emergency consultations, call the DoD ADVISOR
telemedicine hotline (866-972-9966) and select toxicology
from the phone menu.
• For additional information about snakebite management or
this CPG, contact the first author by email or phone
• Email: jordan@snakebitefoundation.org
• Phone: +1-415-218-2211
30
31. Asclepius Snakebite Foundation
JTS Global Snake Envenomation Management (CPG ID: 81)
1. https://www.stripes.com/news/soldier-died-of-venomous-snake-bite-autopsy-confirms-1.334382
2. Berlinger FG, Flowers HH. Some Observations on the Treatment of Snakebites in Vietnam. Mil Med. 1973;138(3):139-143. doi:10.1093/milmed/138.3.139
3. Cline CR, Goodnight ME. Pit viper envenomation in a military working dog. US Army Med Dep J. January 2013:28-33.
4. Roszko PJD, Kavanaugh MJ, Boese ML, Longwell JJ, Earley AS. Rotational thromboelastometry (ROTEM) guided treatment of an Afghanistan viper envenomation at a NATO military hospital. Clin Toxicol
. 2017;55(3):229-230.
5. Heiner JD, Bebarta VS, Varney SM, Bothwell JD, Cronin AJ. Clinical effects and antivenom use for snake bite victims treated at three US hospitals in Afghanistan. Wilderness Environ Med.
2013;24(4):412-416.
6. Shiau DT, Sanders JW, Putnam SD, et al. Self-reported incidence of snake, spider, and scorpion encounters among deployed U.S. military in Iraq and Afghanistan. Mil Med. 2007;172(10):1099-1102.
7. Larréché S, Aigle L, Puidupin M, et al. Animaux venimeux terrestres en opérations extérieures: présentation des principaux risques et du Comité technique des envenimations. Médecine et Armées.
2018;46(1):63-72.
8. Bomba A, Favaro P, Haus R, et al. Review of Scorpion Stings and Snakebites Treated by the French Military Health Service During Overseas Operations Between 2015 and 2017. Wilderness Environ
Med. 2020;31(2):174-180
9. Wilkins D, Burns DS, Wilson D, Warrell DA, Lamb LEM. Snakebites in Africa and Europe: a military perspective and update for contemporary operations. J R Army Med Corps. 2018;164(5):370-379.
10. Haviv J, Huerta M, Shpilberg O, Klement E, Ash N, Grotto I. Poisonous animal bites in the Israel Defense Forces. Public Health Rev. 1998;26(3):237-245.
References cited in this presentation
31